FDA Grants Soligenix "Fast Track" Designation for Dusquetide: A Breakthrough in Behçet's Disease Treatment.
FDA Approval For Behçet's Disease Drug Granted For This Company
FDA Approval For Behçet's Disease Drug…
FDA Approval For Behçet's Disease Drug Granted For This Company
FDA Grants Soligenix "Fast Track" Designation for Dusquetide: A Breakthrough in Behçet's Disease Treatment.